Carbon Dioxide Test as an Additional Clinical Measure of Treatment Response in Panic Disorder

Arquivos de Neuro-Psiquiatria - Brazil
doi 10.1590/s0004-282x2002000300003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

FapUNIFESP (SciELO)

Related search

Management of Treatment-Resistant Panic Disorder

Current Treatment Options in Psychiatry
PsychiatryClinical PsychologyMental Health
2017English

The Dexamethasone Suppression Test in Inpatients With Panic Disorder or Agoraphobia With Panic Attacks

Biological Psychiatry
Biological Psychiatry
1987English

A Proposal for an Additional Clinical Trial Outcome Measure Assessing Preventive Effect as Delay of Events

European Journal of Epidemiology
Epidemiology
2012English

Clinical Characteristics of the Respiratory Subtype in Panic Disorder Patients

Psychiatry Investigation
PsychiatryMental HealthBiological Psychiatry
2014English

Sertraline and Alprazolam in the Treatment of Panic Disorder

Bosnian Journal of Basic Medical Sciences
Medicine
2005English

The Assessment and Treatment of Panic Disorder in General Practice

South African Family Practice
2012English

Clomipramine and Fluoxetine Effects in the Treatment of Panic Disorder

Bosnian Journal of Basic Medical Sciences
Medicine
2003English

Treatment-Free Interval as an Additional Measure of Efficacy in a Large UK Dataset of Transplant Ineligible Myeloma Patients

PLoS ONE
Multidisciplinary
2020English

Cerebrovascular Response to the Cold Pressor Test - The Critical Role of Carbon Dioxide

Experimental Physiology
NutritionPhysiologyDietetics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy